Amphora Discovery
Durham
About Amphora Discovery
Amphora Discovery Corporation operates as a biotechnology company. It provides integrated services to the pharmaceutical industry. The company's products and services include in vitro assay protocols, in vitro throughput screening and compound profiling services, custom assay development, enzymology services, and lead discovery/lead optimization partnering programs. It offers drug discovery contract research services, HTS, profiling and lead generation, and lead optimization solutions. The company serves pharmaceutical and biopharmaceutical companies, emerging biotechnology companies, and research foundations. Amphora Discovery Corporation was founded in 2001 and is headquartered in Durham, North Carolina. As of July 2008, Amphora Discovery Corporation operates as a subsidiary of Nanosyn Inc.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $94.3M
- Funding stage: M&A
- Last round: Series E (Feb 2006)
- Website: amphoracorp.com
Industries & Categories
Biotechnology, Data Integration, Pharmaceutical
Canonical: https://fsome.com/organization/amphora-discovery-2638373 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.